According to the World Health Organization, the average patient adherence to treatments for chronic conditions is about 50%.1 In fact, many patients discontinue therapy after only 6 months.2 Annual US costs from patients not remaining adherent to their medication regimens were $269.4 billion in 2012.3
For patients with type 2 diabetes (T2D), medication nonadherence can lead to episodes of hyperglycemia and other complications, which in turn may lead to increased healthcare costs.4
Patient empowerment has been tied to better medication adherence, increased knowledge of diabetes, better diet and exercise, and regular blood glucose testing.5 To help keep your T2D patient population on track, explore the adherence tools below.